Related Experiment Videos
Pericarditis after therapy with interferon-alpha for chronic hepatitis C.
A Boonen1, R W Stockbrügger, S van der Linden
1Department of Internal Medicine, University Hospital Maastricht, The Netherlands. aboo@SINT.AZM.NL
Clinical Rheumatology
|June 5, 1999
Summary
Pericarditis, an inflammation of the heart sac, can occur after interferon-alpha therapy for chronic hepatitis C. This case highlights a potential adverse effect of this antiviral treatment.
Area of Science:
- Cardiology
- Hepatology
- Pharmacology
Background:
- Chronic hepatitis C viral infection is a significant global health concern.
- Interferon-alpha is a therapeutic agent used for treating chronic hepatitis C.
- Pericarditis is an inflammatory condition affecting the pericardium.
Observation:
- A patient developed pericarditis during interferon-alpha therapy for chronic hepatitis C.
- The onset of pericarditis was temporally associated with the antiviral treatment.
Findings:
- This case suggests a potential link between interferon-alpha treatment and the development of pericarditis.
- The underlying mechanisms for this adverse event warrant further investigation.
Implications:
- Clinicians should be aware of the potential cardiac side effects of interferon-alpha therapy.
- Further research is needed to elucidate the relationship between hepatitis C treatment and pericarditis.